Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Lupin Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Mar 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - LUPIN LTD (LUPIN-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

31 Mar 2015 Thomson Reuters Stock Report 11 $25.00

Lupin Limited (LUPIN) - Financial and Strategic SWOT Analysis Review

Lupin Limited (LUPIN) - Financial and Strategic SWOT Analysis Review Summary Lupin Limited (Lupin) is transnational pharmaceu...

03 Mar 2015 GlobalData 58 $125.00

Company Snapshot - Lupin Limited

Three Directors at Lupin Limited sold 14,800 shares at between 1,698.529INR and 1,700.000INR. The significance rating of the ...

27 Feb 2015 Directors Deals Ltd. 1 $12.00

Company Update | Lupin Ltd. | Lupin receives US FDA approval for generic Lumigan Ophthalmic solution 0.03% from Indore facility; maintain BUY rating with price target of Rs1,777

Company Update | Lupin Ltd. Lupin receives US FDA approval for generic Lumigan Ophthalmic solution 0.03% from Indore facili...

23 Feb 2015 IndiaNivesh Securities Pvt Ltd 2 $12.00

Wright Investors Service Comprehensive Report for Lupin Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Feb 2015 Wright Reports 55 $75.00

Result Update (Lupin Limited)

Result Update (Lupin Limited)

09 Feb 2015 SMC Global Securities Limited 3 $23.00

Lupin Ltd. - Q3FY15 Result Update - "ACCUMULATE" - KRChoksey Research - ”Top line missed estimates due to slowdown in US business.”

”Top line missed estimates due to slowdown in US business.” Result highlights Lupin’s sales grew by 5.4% YoY to Rs3178crs bel...

05 Feb 2015 Kisan Ratilal Choksey Shares and Securities Private Limited 7 $58.00

MOSL: LUPIN (Buy) - Stronger margins compensate for topline miss - Outlook robust

LUPIN 3QFY15: Stronger margins compensate for topline miss - Outlook robust (LPC IN, Mkt Cap USD11.0b, CMP INR1545, TP INR18...

04 Feb 2015 Motilal Oswal Securities Ltd. 14 $150.00

Lupin Limited (LUPIN) - Financial and Strategic SWOT Analysis Review

Lupin Limited (LUPIN) - Financial and Strategic SWOT Analysis Review Summary Lupin Limited (Lupin) is transnational pharmaceu...

04 Feb 2015 GlobalData 55 $125.00